| For: | Wang W, Guo MN, Li N, Pang DQ, Wu JH. Glutamine deprivation impairs function of infiltrating CD8+ T cells in hepatocellular carcinoma by inducing mitochondrial damage and apoptosis. World J Gastrointest Oncol 2022; 14(6): 1124-1140 [PMID: 35949216 DOI: 10.4251/wjgo.v14.i6.1124] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i6/1124.htm |
| Number | Citing Articles |
| 1 |
Amino acid metabolism in glioblastoma pathogenesis, immune evasion, and treatment resistance. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03721-1
|
| 2 |
Mengxiao Lu, Yingjie Wu, MinMing Xia, Yixin Zhang. The role of metabolic reprogramming in liver cancer and its clinical perspectives. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1454161
|
| 3 |
Gengtian Zhang, Mengyao Bai, Hanzhi Du, Yue Yuan, Yidan Wang, Weijing Fan, Huachao Zhu, Di Wu, Pengcheng He, Busheng Xue. Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors. ImmunoTargets and Therapy 2025; doi: 10.2147/ITT.S519616
|
| 4 |
Guoqing Xiang, Zhicheng Zhou, Xue Jiang, Zhenguang Du, Yangyang Zhan, Xinli Liu. The Cancer Cell Metabolic Reprogramming Remodels the Tumor Microenvironment: Molecular Mechanisms and Therapeutic Strategies. Advanced Science 2026; doi: 10.1002/advs.77424
|
| 5 |
Sifan Feng, Kentaro Hisada, Haruna Yorifuji, Yoshifumi Shirakami, Kazuko Kaneda-Nakashima. Astatine-211-Labeled Therapy Targeting Amino Acid Transporters: Overcoming Drug Resistance in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences 2025; 26(21) doi: 10.3390/ijms262110736
|
| 6 |
Xiaoxia Feng, Yanjun Zhang, Ousman Bajinka, Serge Yannick Ouedraogo, Yuping Zhang, Na Li, Xianquan Zhan. Molecular and cellular landscapes of the immune microenvironment and multiomic biomarker-sets in platinum-resistant recurrent ovarian cancers. Journal of Ovarian Research 2026; 19(1) doi: 10.1186/s13048-026-02050-9
|
| 7 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Nutrition deprivation affects the cytotoxic effect of CD8 T cells in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2022; 14(9): 1887-1891 doi: 10.4251/wjgo.v14.i9.1887
|
| 8 |
Liming Liao, Huilin Xu, Yuhan Zhao, Xiaofeng Zheng. Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies. Frontiers of Medicine 2023; 17(5) doi: 10.1007/s11684-023-1025-7
|
| 9 |
Chenshuang Dong, Yan Zhao, Yecheng Han, Ming Li, Guiling Wang. Targeting glutamine metabolism crosstalk with tumor immune response. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(1) doi: 10.1016/j.bbcan.2024.189257
|
| 10 |
Usman Humayun Temuri. Immunosuppressive cell populations as potential drivers of extrinsic immune checkpoint inhibition resistance in clear cell renal cell carcinoma. Oncology Reviews 2026; 20 doi: 10.3389/or.2026.1953850
|
| 11 |
Karen Slattery, Gearóid Conlon, Ethan Collins, Derek P. Nolan, Clair M. Gardiner, Geraldine M. O’Connor. Metabolic tracing reveals IL-2 driven glutaminolysis and de novo pyrimidine synthesis in human natural killer cells. Journal of Biological Chemistry 2026; 302(5) doi: 10.1016/j.jbc.2026.111367
|
| 12 |
Bing Yue, Yuxia Gao, Yi Hu, Meixiao Zhan, Yangzhe Wu, Ligong Lu. Harnessing CD8+ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions. Clinical and Translational Medicine 2024; 14(7) doi: 10.1002/ctm2.1731
|
| 13 |
Maria Pires Pacheco, Jimmy Ji, Tessy Prohaska, María Moscardó García, Thomas Sauter. scFASTCORMICS: A Contextualization Algorithm to Reconstruct Metabolic Multi-Cell Population Models from Single-Cell RNAseq Data. Metabolites 2022; 12(12) doi: 10.3390/metabo12121211
|
| 14 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Nutrition deprivation affects the cytotoxic effect of CD8 T cells in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2022; 14(9) doi: 10.4251/wjgo.v14.i9.1886
|
| 15 |
Lin Chen, Hanyu Zhang, Yunlong Wang, Xianhu Feng, Yi Hou, Qiang Su. Photothermal therapy triggering organelle stress and metabolic reprogramming to potentiate antitumor immunity. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1890839
|
| 16 |
Ruichen Yuan, Yuejiao Lan, Mingda Wu, Xiaodan Lu. The role of hormonal and nutritional biomarkers in predicting immune checkpoint inhibitor efficacy: current limitations and future prospects. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1857147
|
| 17 |
Huali Fan, Shizhuo Yang, Qing Lu, Liming Chang. Metabolic reprogramming and immunosenescence: a new sight for glioma therapy. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1754980
|
| 18 |
Xu Chen, Pei Lin, Ye Lu, Jiarong Zheng, Yunfan Lin, Zihao Zhou, Li Cui, Xinyuan Zhao. Mitochondrial Regulation of CD8⁺ T Cells: Mechanisms and Therapeutic Modulation. Advanced Science 2025; 12(32) doi: 10.1002/advs.202503095
|
| 19 |
Yang Wang, Yi-Jun Lu, Jian Zhou, Xin-Rong Yang. Impact of metabolic reprogramming on the immune response in hepatocellular carcinoma. Hepatoma Research 2026; doi: 10.20517/2394-5079.2025.105
|
| 20 |
Barbara Janota, Barbara Szymanek. The Influence of Diet and Its Components on the Development and Prevention of Hepatocellular Carcinoma (HCC). Cancers 2024; 16(5) doi: 10.3390/cancers16051030
|
| 21 |
Jie Xiao, Ting Liu, Fanxin Zeng, Jinhua Zhang. New insights into T cell metabolism in liver cancer: from mechanism to therapy. Cell Death Discovery 2025; 11(1) doi: 10.1038/s41420-025-02397-w
|
| 22 |
Huiru Zhang, Jialiang Fan, Deyang Kong, Yu Sun, Qi Zhang, Renshen Xiang, Shuaibing Lu, Wenjing Yang, Lin Feng, Haizeng Zhang. Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy. Molecular Cancer 2025; 24(1) doi: 10.1186/s12943-025-02460-1
|
| 23 |
Vijay Kumar, John H. Stewart. Immunometabolic reprogramming, another cancer hallmark. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1125874
|
| 24 |
Jian Lin, Dongning Rao, Mao Zhang, Qiang Gao. Metabolic reprogramming in the tumor microenvironment of liver cancer. Journal of Hematology & Oncology 2024; 17(1) doi: 10.1186/s13045-024-01527-8
|
| 25 |
Andrea C. Fox, John Blazeck. Applying metabolic control strategies to engineered T cell cancer therapies. Metabolic Engineering 2024; 86 doi: 10.1016/j.ymben.2024.10.009
|
| 26 |
Yuqi Xu, Wenhui Yuan, Ke Li, Peng Li. Nutritional intervention alleviates T cell exhaustion and empowers anti-tumor immunity. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1689317
|
| 27 |
Kyra Laubach, Tolga Turan, Rebecca Mathew, Julie Wilsbacher, John Engelhardt, Josue Samayoa. Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment. Cancer Drug Resistance 2023; 6(3) doi: 10.20517/cdr.2023.60
|
| 28 |
Subha Ranjan Das, Igor Koman, Elimelech Nesher. Mechanistic target of rapamycin complex (mTORC)-glutamine axis in cancer: Mechanistic crosstalk, therapeutic resistance, and clinical opportunities. Cancer Pathogenesis and Therapy 2026; doi: 10.1016/j.cpt.2026.08.003
|